Synergistic effects of taurine and L-arginine on attenuating insulin resistance hypertension

Adv Exp Med Biol. 2013:775:427-35. doi: 10.1007/978-1-4614-6130-2_32.

Abstract

To elucidate the synergistic effects of taurine and L-arginine on hypertension, 25% fructose were administered to male Wistar rats for 3 months to establish insulin resistance hypertensive models. Rats with the systolic blood pressure (SBP) higher than 150 mmHg were considered as model rats. Forty-two model rats were randomly divided into six groups and administered with 3% taurine, 2.7% taurine + 0.3% L-arginine, 2.1% taurine + 0.9% L-arginine, 1.5% taurine + 1.5% L-arginine and 3% L-arginine in drinking water respectively. The results showed that coadministration of taurine (1.5%) and L-arginine (1.5%) could bring the levels of SBP, blood glucose, and insulin down to normal levels after 4 weeks. The thickness of blood vessels increased significantly in model group, which could be reversed by taurine and L-arginine. Serum NO, cGMP, and ET levels could return to normal levels. These data indicated that both taurine and L-arginine could ameliorate vascular remodeling and showed obvious antihypertensive effects, and taurine (1.5%) and L-arginine (1.5%) in the drinking water showed a better result in the cure of hypertension.

MeSH terms

  • Animals
  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use*
  • Arginine / pharmacology
  • Arginine / therapeutic use*
  • Blood Glucose / metabolism
  • Blood Pressure / drug effects
  • Cyclic GMP / blood
  • Drug Synergism
  • Endothelins / blood
  • Hypertension / blood
  • Hypertension / drug therapy*
  • Hypertension / pathology*
  • Hypertension / physiopathology
  • Insulin / blood
  • Insulin Resistance*
  • Male
  • Nitric Oxide / blood
  • Rats
  • Rats, Wistar
  • Systole / drug effects
  • Taurine / pharmacology

Substances

  • Antihypertensive Agents
  • Blood Glucose
  • Endothelins
  • Insulin
  • Taurine
  • Nitric Oxide
  • Arginine
  • Cyclic GMP